Original Paper

Oncogene (2005) 24, 6143–6154. doi:10.1038/sj.onc.1208756; published online 20 June 2005

Synergistic induction of the MUC4 mucin gene by interferon-bold italic gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways

Mahefatiana Andrianifahanana1, Anshu Agrawal1, Ajay P Singh1, Nicolas Moniaux1, Isabelle van Seuningen2, Jean-Pierre Aubert2, Jane Meza3 and Surinder K Batra1

  1. 1Department of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA
  2. 2Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA
  3. 3INSERM, Place de Verdun, 59045 Lille Cedex, France

Correspondence: SK Batra, sbatra@unmc.edu

Received 20 September 2004; Revised 1 April 2005; Accepted 1 April 2005; Published online 20 June 2005.

Top

Abstract

The transmembrane mucin, MUC4, is aberrantly expressed with a high incidence in human pancreatic adenocarcinomas and plays an important role in the pathogenesis of the disease. Our recent studies have shown that interferon-italic gamma (IFNitalic gamma) and retinoic acid (RA) are important regulators of MUC4 in pancreatic tumour cells. Induction of MUC4 by IFNitalic gamma occurs via a novel pathway involving upregulation of the signal transducer and activator of transcription 1 (STAT-1), whereas its stimulation by RA requires mediation by the transforming growth factor beta-2 (TGFbeta-2). In this study, we have investigated the molecular mechanisms underlying the interaction of IFNitalic gamma and RA in MUC4 regulation in pancreatic tumour cells. We demonstrate that these reagents exert a synergistic induction of MUC4. Interestingly, while the upregulation of STAT-1 by IFNitalic gamma is partially inhibited by RA, IFNitalic gamma is shown to repress RA-driven TGFbeta-2 induction, pointing to the involvement of alternative mechanism(s) in IFNitalic gamma–RA synergism. Moreover, a dose-dependent and cooperative induction of MUC4 promoter activity suggests a regulation at the transcriptional level, most likely by STAT-1 and RAR/RXR (RA receptor/retinoic X receptor) or other IFNitalic gamma/RA-induced secondary intermediate effectors. Our findings provide potential mechanisms that may account for the aberrant expression of MUC4 in pancreatic tumour cells and expose a novel molecular mechanism of gene induction, whereby a reprogramming of signalling pathway through alternative route(s) operates during a synergistic interaction of biological modifiers.

Keywords:

MUC4 mucin, IFNitalic gamma, retinoic acid, synergism, gene regulation, pancreatic cancer

Extra navigation

.

naturejobs

ADVERTISEMENT